SEC Form 4 · accession 0001127602-19-003363
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander J Denner
Director
Period of report
Jan 30, 2019
Accepted (ET)
Feb 1, 2019 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 30, 2019 | P | 30,000 | $324.8617 | A | 491,858 | I | See Footnotes |
| Common StockF1,F2 | Jan 31, 2019 | P | 25,800 | $330.5191 | A | 517,658 | I | See Footnotes |
| Common StockF1,F2 | Feb 1, 2019 | P | 7,000 | $328.4518 | A | 524,658 | I | See Footnotes |
| Common Stock | holding | — | — | — | 10,909 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dr. Denner disclaims beneficial ownership of the shares being reported on this Form 4 except to the extent of his pecuniary interest therein.
- F2Sarissa Capital Management GP LLC, a Delaware limited liability company ("Sarissa Capital GP"), is the general partner of Sarissa Capital Management LP, a Delaware limited partnership ("Sarissa Capital"), the investment advisor to certain investment funds. Alexander Denner is the Chief Investment Officer of Sarissa Capital and the managing member of Sarissa Capital GP. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the shares that those funds directly beneficially own.